Professional Perspectives | GPnotebook Resources

This site is intended for UK and Irish healthcare professionals only

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. This Boehringer Ingelheim (BI) & Lilly Alliance webpage is hosted on GPnotebook on behalf of the BI & Lilly Alliance. GPnotebook is published by Oxbridge Solutions Ltd^®, a subsidiary of OmniaMed Communications Ltd. Diabetesonthenet is published by OmniaMed Communications Ltd. Copyright 2023 Oxbridge Solutions Ltd^®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions Ltd^® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.

Advertise with us

Terms and conditions

Sign up

You can sign up here to receive and manage your electronic communications from Boehringer Ingelheim about BI’s products, services and events.

To request further information please tick the relevant box below and submit this form*.

I'd like to:
receive further information via email arrange a representative visit or online meeting

Name*

Email*

Organisation name*

Contact number*

Work postcode*

GMC or registration number*

*By submitting this form, your details will be passed directly to our client, Boehringer Ingelheim. By requesting further information, you are consenting to receive emails regarding Boehringer Ingelheim products and services. If you have indicated this above, you will be offered the option to arrange a representative visit either in person or via an online remote detailing service according to your requirements. You are under no obligation to grant an interview. Your details will not be disclosed to any other third parties and will only be used to contact you in relation to this product or service.

I confirm that I have read the Boehringer Ingelheim Privacy Policy

NP-GB-103570 | April 2023

You are leaving GP Notebook

This link will take you to a third party website. GP Notebook does not control or endorse this third party website and is not responsible for its content or privacy policy

Continue

Close

You are leaving GP Notebook

This link will take you to a third party website. GP Notebook does not control or endorse this third party website and is not responsible for its content or privacy policy

Continue

Close

Prescribing information for Great Britain and Northern Ireland

Adverse events should be reported. Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard (UK) or https://www.hpra.ie/homepage/about-us/report-an-issue (IRE). Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone) (UK) or 01 2913960 (IRE), Fax: +44 1344 742661, or by e-mail: [email protected].

You are leaving this site.

You are now leaving https://resources.gpnotebook.com/moving-forward-in-type-2-diabetes-management-with-glp-1ras-resource-hub/.
Links to external website are provided as a resource to the viewer.
This website is neither owned or controlled by Novo Nordisk.
Novo Nordisk accepts no responsibility for the content or services of the linked site.

OK

Cancel